跳至主要内容
临床试验/NL-OMON41814
NL-OMON41814已完成不适用

Web-based tailored Information and support for patients with a Neuroendocrine tumor - WIN-study

niversitair Medisch Centrum Groningen0 个研究点目标入组 90 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • Adult NET patients (aged >= 18 years of age) with any tumor site and disease stage.
  • Ability to comprehend Dutch (both reading and writing).
  • Informed consent provided.

排除标准

  • Estimated life expectancy less than 3 months.
  • Patients who have a history of another primary malignancy, except for radical and adequately treated malignancies from which the patient has been disease free for >= 3 years
  • Patients who participated in the WIN-pilot study.

研究者

相似试验